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ubstance use disorders (SUDs) are characterized as “maladaptive pat-
terns of substance use leading to clinically severe impairment or distress” 
potentially affecting physical or psychological functioning; personal safety; 
social relations, roles, and obligations; work; and other areas (American Psychiatric 
Association, 1994). Substance abusers seek help quitting drugs not as an end in 
itself, but as a means to escape these negative consequences and to gain a better 
life. Accordingly, while substance abuse treatment seeks to promote abstinence or 
at least significant reductions in substance use, its ultimate aim is to improve the 
patient’s quality of life (QOL). In this paper, I present current concepts of QOL 
and tools used to measure it, summarize recent paradigmatic shifts in the SUD 
field that are leading to an emerging interest in QOL, and review the evidence 
bearing on QOL in the treatment of addiction. Finally, I present the implications 
of incorporating QOL concepts into clinical practice and research.
CURRENT CONCEPTS OF QUALITY OF LIFE
QOL describes clients’ experiences in aspects of functioning that are important to 
them but are not captured by traditional symptom assessments such as the Addic-
tion Severity Index (ASI) (Donovan et al., 2005). To date, there is no universally 
accepted biomedical definition of QOL, but there is consensus that it incorpo-
rates the individual’s subjective view of a broad range of clinical, functional, and 
personal variables (Bonomi et al., 2000a).
Researchers have conceptualized two types of QOL (Table 1). The first, health-
related QOL (HRQOL), is a patient’s perception of how his or her health
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status affects physical, psychological, and social func-
tioning and well-being (Leidy, Revicki, and Geneste, 
1999). HRQOL is assessed using instruments such as 
the Short Form 36 Health Survey (SF-36) or the abbre-
viated SF-12, with questions such as “Does your health 
problem prevent you from walking one block?” (Stewart 
and Ware, 1989). In its focus on limitations caused by 
disease and treatment, HRQOL aligns with traditional 
pathology-focused care.
In contrast, generic or overall QOL (OQOL) encom-
passes the patient’s satisfaction with life in general, not 
solely in relation to disease-related limitations on func-
tioning. One influential definition of OQOL, drafted 
by the World Health Organization (WHO), is “an 
individual’s perception of their position in life in the 
context of the culture and value systems in which they 
live and in relation to their goals, expectations, standards 
and concerns” (WHOQOL Group, 1995). The gold 
standards for measuring OQOL are the World Health 
Organization Quality of Life (WHOQOL) instrument 
and its shorter version, the WHOQOL-BREF (WHO-
QOL Group, 1998), which assess the patient’s perception 
of how he or she is functioning objectively (e.g., “how is 
your memory?”) and how he or she feels about it (e.g., 
“how satisfied are you with your memory?”). These 
and other OQOL assessments cover not only the three 
domains of functioning included in HRQOL but also, 
for example, environment, safety, finances, access to 
transportation and health services, and opportunities for 
recreation and leisure. Reporting on the U.S. validation 
of the WHOQOL instrument, Bonomi and colleagues 
(2000b) noted that “these additional factors … have been 
found important to individuals, groups and society, and 
are integral in describing overall QOL.” 
  HEALTH-RELATED QUALITY OF LIFE (HRQOL) OVERALL QUALITY OF LIFE (OQOL)
Definition An individual’s perception of the effects of illness on 
the physical, mental, and social dimensions of his/
her well-being
An individual’s perception of his/her position in life in the 
context of the culture and value systems in which he/she lives 
and as related to his/her goals, expectations, standards, and 
concerns 
Paradigm Symptoms, pathology Wellness
Instrument SF-36, SF-12 WHOQOL-100, WHOQOL-BREF
Domains Physical, mental, social health Physical, mental (including spiritual), and social health, and liv-
ing environment (e.g., housing, finances, safety, access to care)
What is 
assessed
Limitations in functioning due to disease Objective functioning and satisfaction with functioning
Treatment 
focus
Symptom reduction Maximized overall functioning and life satisfaction
TABLE 1. Summary of Prevalent Concepts and Measurements of Quality of Life 
THE WORLD HEALTH ORGANIZATION QUALITY OF LIFE 
BREF INSTRUMENT (WHOQOL-BREF)
The WHOQOL-BREF assesses individuals’ quality of life overall, not only 
in relation to health problems. The scope of the inquiry may be suggested 
by the following questions, selected from among a total of 26. Patients are 
instructed to keep in mind their “standards, hopes, pleasures and concerns” 
as they respond to each with a rating of 1 to 5. 
• To what extent do you feel your life to be meaningful? 
• How well are you able to concentrate? 
• Have you enough money to meet your needs? 
• To what extent do you have the opportunity for leisure activities? 
• How well are you able to get around? 
• How satisfied are you with your capacity for work? 
• How satisfied are you with your personal relationships? 
• How satisfied are you with your access to health services?
The full WHOQOL-BREF is posted at www.who.int/substance_abuse/
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Clinical Relevance
The subjective views elicited by QOL measures are 
important because they offer a complementary per-
spective to that of clinicians. Clinicians tend to focus on 
symptoms, whereas for clients, symptom management 
is a means to an end: optimal well-being (“recovery” 
in the substance abuse field). As a result, clinicians and 
clients often differ in their ratings of quality of care. In 
general, patients’ views provide unique information and 
insights into both the humanity and the effectiveness of 
health care (Black and Jenkinson, 2009). 
QOL assessments serve as both evaluation and diag-
nostic tools (Rudolf and Watts, 2002). They coincide 
with the treatment goal of enhanced client functioning 
and predict treatment adherence (Smith and Larson, 
2003). Moreover, some evidence suggests that QOL 
has prognostic value in treatment settings; for example, 
higher pretreatment QOL predicts better outcomes in 
inpatient psychiatric units, independent of baseline 
psychiatric status and other relevant factors (Smith and 
Larson, 2003). Finally, as will be discussed, QOL may 
influence the odds of symptom reduction.
QOL measures can greatly assist clinicians in select-
ing and assessing the effectiveness of a specific course of 
treatment. Their use is in keeping with a growing interest 
throughout the health field in models that engage patients 
as partners in their own care (Black and Jenkinson, 2009; 
Rudolf and Priebe, 2002). The WHO defines health as 
“a state of complete physical, mental, and social well-
being, not merely the absence of disease” (World Health 
Organization, 1985). QOL takes on its full importance as 
a diagnostic and outcome measure when health is thought 
of in this way. Indications of a growing recognition of 
the critical value of patients’ reports on their own health 
include the recent launch of the National Institutes of 
Health (NIH) Patient-Reported Outcomes Measurement 
Information System (PROMIS) initiative to “address 
the pressing need to better quantify clinically important 
patient-reported symptoms and aspects of health-related 
QOL across chronic conditions” and recent Food and 
Drug Administration (FDA) guidelines in which QOL 
outcomes count as key evidence to support claims in 
medical product labeling (www.fda.gov/downloads/Drugs/
GuidanceComplianceRegulatoryInformation/Guidances/
UCM193282.pdf). 
Increasing QOL and longevity were two of the goals 
of NIH’s Healthy People 2010 (U.S. Department of 
Health and Human Services, 2000) and remain cen-
tral goals in Healthy People 2020 (www.healthypeople.
gov/2020/default.aspx). Biomedical research is gradually 
shifting from the traditional paradigm of evaluating 
interventions by assessing disease-specific outcomes to a 
new paradigm that incorporates or is complemented by 
QOL outcomes. Large-scale biomedical clinical trials now 
routinely include QOL as, at least, a secondary endpoint 
and often as a primary outcome; more than 7,000 articles 
were listed in Index Medicus under the keyword “qual-
ity of life” in 2003 (Donovan et al., 2005). Whereas, in 
1990, QOL could be called “the missing measurement 
in health” (Fallowfield, 1990), today virtually no area of 
medicine is without published studies on QOL.
RELEVANCE OF QUALITY OF LIFE IN  
SUBSTANCE ABUSE TREATMENT
The nature of SUD makes consideration of QOL, par-
ticularly OQOL, highly relevant. First, active substance 
abuse affects nearly all areas of functioning—vocational, 
social/familial, physical and mental health, residential 
status, and access to services (American Psychiatric Asso-
ciation, 1994). Commenting on findings from a study 
of individuals’ reasons for seeking treatment for alcohol 
abuse, researchers noted that “the most striking aspect 
… was the sheer number of problems that people were 
experiencing” (Orford et al., 2006, p. 167). 
Individuals want SUD services to address the full 
range of problems that prevent them from living fully 
and are more likely to drop out if such help is not forth-
coming. When my colleagues and I examined polydrug 
abusers’ reasons for dropping out of outpatient treatment, 
33 percent said they might have stayed if the program 
had done something differently; of these, 54 percent 
cited unmet social service needs, especially vocational/
educational and housing (Laudet, Stanick, and Sands, 
2009). 
The relevance of broad QOL domains, as measured 
by the WHOQOL instruments, to the recovery experi-
ence is bolstered by findings of a recent study of recovery 
priorities among community-based persons in recovery 
for periods ranging from 1 month to more than 10 years. 
We found that, in addition to concern about remaining 
abstinent, participants at all stages of recovery expressed 
concerns about multiple areas of functioning—most 
notably, employment, education and training, and hous-
ing (Laudet and White, 2009). 
Widely used measures, such as the ASI, evaluate 
patients’ experiences in key domains that are found 
to be problematic for many. However, QOL instru-
ments are more comprehensive and are also likely more 
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end.relevant to persons in long-term recovery who are no 
longer receiving services but continue to struggle with 
addiction-related sequelae.
SUD is a chronic condition for most affected individ-
uals, and QOL improvement is a particularly important 
goal in treating conditions that cannot be cured. QOL 
measurement in a chronic illness framework intends 
to capture the full impact of a medical condition and 
recommended treatment on an individual (WHOQOL 
Group, 1995). As a commonly used outcome measure in 
chronic illnesses, QOL provides an empirical assessment 
of how patients experience functioning and the burden 
of disease after treatment (Mendlowicz and Stein, 2000), 
which is useful information for public health evaluations 
and for service development and evaluation.
In accord with the growing medical recognition 
that patients require improved function in broad areas, 
the SUD field has been revising the concept of recov-
ery. Although abstinence from drugs and alcohol was 
traditionally considered a proxy for good function in 
other areas, that assumption no longer holds (McLellan, 
Chalk, and Bartlett, 2007). To the contrary, abstinence 
rarely brings instant relief from all other problems in life 
(Vaillant, 1995), and it is common to see reductions in 
drug use without concurrent improvement elsewhere, 
especially early on (Dennis, Foss, and Scott, 2007). A 
consensus is emerging that recovery—the common goal 
of clinicians, clients and their families, funders, policy-
makers, and society at large—is best conceptualized as 
abstinence plus improvements in global functioning or, 
in other words, improved QOL. Thus, the Substance 
Abuse and Mental Health Services Administration 
(SAMHSA) defines recovery as “a process of change 
through which an individual achieves abstinence and 
improved health, wellness, and quality of life” (Center for 
Substance Abuse Treatment, 2006). Similarly, but more 
colloquially, former SAMHSA Director Charles Curie 
has said, “Recovery is when patients are not just free of 
symptoms—they have a life” (Curie, 2005). Consistent 
with this stance, QOL domains are central to SAMHSA’s 
National Outcome Measures (NOMs) (Substance Abuse 
and Mental Health Services Administration, 2004), 
which are used to evaluate all publicly funded services 
(integratedrecovery.org/wp-content/uploads/2010/08/
SAMHSA-National-Outcome-Measures.pdf) and are a 
key part of NIH’s PROMIS initiative (www.nihpromis.
org/default.aspx).
These changes in the understanding of SUDs have 
given rise to a new service model that relies on patients’ 
experiences, especially their reports of well-being or 
QOL, to guide and evaluate service provision. Called 
“recovery-oriented systems of care” (ROSC; www.pfr.
samhsa.gov/rosc.html), the model offers person-centered, 
strength-based continuity of care for individuals, families, 
and communities to take responsibility for their health, 
wellness, and recovery from alcohol and drug problems 
(Clark, 2008). In line with calls from the Institute of 
Medicine and leading addiction researchers for a shift 
in SUD treatment from the acute care model to one 
more akin to the model used in other chronic conditions 
(Institute of Medicine, 2005; McLellan et al., 2000; 
White et al., 2005), the recommended range of services 
is intended to respond to clients’ changing needs across 
their lifespan. ROSC offers a comprehensive menu of 
services and supports that can be coordinated and inte-
grated to meet the individual’s needs and chosen path to 
improved function and a better life. Clients may receive 
help with education and job training, housing, child 
care, transportation to and from treatment and work, 
case management, as well as SUD-related services (e.g., 
relapse prevention, recovery support, SUD education 
for family members, peer-to-peer services and coaching, 
self-help, and support groups) (Kaplan, 2008).
THE IMPACT OF SUBSTANCE ABUSE ON 
QUALITY OF LIFE
The addiction field lags far behind other mental health 
and biomedical disciplines in embracing QOL as an 
essential outcome, especially in the United States (Mor-
gan et al., 2003). Systematic use of QOL indicators to 
monitor outcomes has been scarce, despite the wide-
ranging effects of SUD on patients, families, and society 
(Dawson et al., 2009; Préau et al., 2007). Fewer than 
100 studies of QOL among SUD populations have been 
published in English in the past 20 years (e.g., Donovan 
et al., 2005; Morgan et al., 2003; Rudolf and Watts, 
2002; Smith and Larson, 2003), and almost all of them 
involve alcohol-dependent subjects. Most QOL studies 
of drug-abusing populations have been conducted out-
side of the United States and involved dually diagnosed 
persons (those with mental illness and SUD) and/or 
opiate abusers (Bizzarri et al., 2005; Millson et al., 2006; 
Puigdollers et al., 2004; Villeneuve et al., 2006). Aside 
from our own work, we found only one QOL study of 
crack/cocaine-dependent individuals (Havassy and Arns, 
1998). Some studies have yielded information on QOL 
without using the term; for example, many have used 
the ASI, which assesses clients’ level of functioning in 
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some QOL areas. Even so, only 38 percent of multigroup 
studies published between 1990 and 1998 reported on 
psychological functioning, the non-substance-abuse 
outcome most frequently examined. Moreover, studies 
focusing on QOL have almost all looked at HRQOL 
rather than OQOL, even though the latter relates more 
directly to recovery goals.
What follows is a summary of the current state of 
knowledge on well-being/QOL in substance-abusing 
populations. Because of the dearth of studies among 
drug-dependent populations, evidence among both 
alcohol- and drug-abusing individuals is reviewed.
QOL Among Active Substance Abusers and   
Treatment Seekers
QOL is poorer among substance-dependent individuals 
and SUD treatment seekers than among cohorts with-
out SUD (Donovan et al., 2005; Rudolf and Watts, 
2002; Smith and Larson, 2003). This finding is consis-
tent across comparisons with clinical and nonclinical 
cohorts, primary care patients, groups with chronic 
physical or mental health conditions, and healthy nona-
busers (Foster, Peters, and Marshall, 2000; Kraemer 
et al., 2002; Smith and Larson, 2003). For example, 
on the SF-36 indices of physical and mental function-
ing, clients in SUD treatment score significantly lower 
than the general population, as low as or lower than 
patients with lung disease and diabetes, and significantly 
lower than patients awaiting cardiac surgery (Smith 
and Larson, 2003). 
While the evidence is equivocal regarding negative 
impacts of SUD on physical functioning (Morgan et 
al., 2003; Stein et al., 1998), SUD is clearly associated 
with severe impairments across several other functional 
domains. Mental functioning is particularly affected 
(Preau et al., 2007; Smith and Larson, 2003; Volk et 
al., 1997), as are social and physical role function (daily 
activities, work), general health perception, employ-
ment, and leisure activities (Hubbard, Craddock, and 
Anderson, 2003; Smith and Larson, 2003).
A large study of methamphetamine-dependent 
patients enrolled in treatment found that at intake, 
participants’ health status, as measured by the SF-36, 
was substantially lower than that of the normative U.S. 
population. Their lowest scores were in overall mental 
health and mental health subscales, including vitality, 
social functioning, and emotional well-being (Gonzales 
et al., 2009). They also reported poorer general health 
and more physical role limitations than the population 
as a whole, although there were no differences in overall 
physical health status.
Correlates of QOL  
in SUD Populations 
Sociodemographic and clinical variables have been stud-
ied most as predictors of QOL in SUD populations. 
The findings are somewhat inconsistent and difficult 
to interpret because of  differences in methodologies, 
instruments, domains, and populations (Morgan, Lan-
dron, and Lehert, 2004). Overall, however, younger age, 
higher education, male gender, and being employed are 
consistently associated with better functioning on all 
HRQOL dimensions, when other covariates are held 
constant (Donovan et al., 2005; Foster et al., 2000; 
Youssef, Moubarak, and Kamel, 2005). Comorbid psy-
chiatric and physical conditions, including HIV and/or 
hepatitis C infection, are linked to greater impairment of 
functioning (Millson et al., 2006; Morgan et al., 2003; 
Puigdollers et al., 2004). 
In general, the greater the number of chronic con-
ditions a person has, the higher the risk for functional 
impairment in all QOL dimensions (Thommasen and 
Zhang, 2006). As expected, physical and mental comor-
bidity associate most strongly with impairments in physi-
cal and mental functioning, respectively (Gunther et al., 
2007); however, either raises the odds of impairments in 
almost all life domains (Bizzarri et al., 2005; Fassino et 
al., 2004; Villeneuve et al., 2006). Nevertheless, across 
studies, the combined influence of known demographic 
and clinical variables has accounted for only 2 to 7 per-
cent of the variance in HRQOL among SUD treatment 
seekers (Stein et al., 1998), suggesting that other factors 
are at play and additional research is needed.
An important question and an emerging area of 
research is the extent to which substance abuse affects 
QOL in itself, independently of other factors. Greater 
number and severity of alcohol or drug problems each 
consistently associates with poorer functioning in nearly 
all QOL domains (McKenna et al., 1996; Volk et al., 
1997), but other commonly used dependence indices, 
such as age at onset of drug use, duration of dependence, 
drinking pattern, prior withdrawal distress, and number 
of prior treatments, are not reliably predictive of QOL 
(Millson et al., 2006). Drug abuse may impair func-
tioning more than alcohol abuse (Smith and Larson, 
2003), and this may be especially true of cocaine and 
polysubstance abuse (Havassy and Arns, 1998; Puig-
dollers et al., 2004).
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Intuitively, one might expect reduced SUD symptoms 
and abstinence to be accompanied by significant improve-
ments in QOL, and there is evidence that QOL improves 
with abstinence and deteriorates in relapse (Kraemer et 
al., 2002; Villeneuve et al., 2006). Studies most consis-
tently link reduced drug and alcohol abuse and abstinence 
with improved mental functioning (Foster et al., 2000). 
For example, the most methodologically sophisticated 
investigation of SUD’s influence on QOL found that 
individuals in a general population sample whose drink-
ing patterns fluctuated—between no drinking, controlled 
drinking, alcohol abuse, and alcohol dependence—dur-
ing a 3-year followup were more likely to experience 
related changes in their mental than in their physical 
functioning (Dawson et al., 2009). Participants who 
developed an alcohol use disorder or progressed from 
abuse to dependence experienced substantial declines in 
mental functioning, whereas all forms of remission were 
independently associated with substantially improved 
mental functioning. Increases associated with abstinent 
and nonabstinent remission were about twice as large as 
those seen with partial remission (i.e., not meeting criteria 
for dependence but having one or more symptoms of 
abuse or dependence).
Consistent with the view that reduced substance 
abuse is not in itself an adequate criterion for recovery, 
its impact on mental functioning appears to be small. 
For example, Morgan and colleagues (2003) studied 
252 adults in an outpatient randomized clinical trial 
and estimated that reduced drug abuse accounted for 4.8 
percent of variance in mental functioning at the 3-month 
followup. Moreover, studies have not consistently shown 
that reducing substance abuse affects domains of QOL 
other than mental functioning. For example, among 
dually diagnosed clients, researchers found no correlation 
between the extent of reduction in substance abuse 3 
years post-intake and changes in general life satisfaction, 
social and family contact, or satisfaction with contacts 
(McHugo et al., 1999).
As with other positive treatment outcomes, a critical 
question is whether gains in QOL resulting from reduc-
tions in substance abuse endure. Very little research has 
addressed this issue, and the relationship between dura-
tion of abstinence and QOL remains unclear (Rudolf 
and Watts, 2002). Mann and colleagues followed a 
cohort of alcoholics for 6 years; at the final assessment, 
65 percent of the group had been abstinent for 4 years 
or more, and these individuals had markedly superior 
physical, psychological, social, and everyday life function-
ing compared with those still drinking (Mann, Morlock, 
and Mezger, 1997). The positive relationship between 
abstinence duration and QOL has been described as 
linear in short-term studies (McKenna et al., 1996); 
however, a handful of cross-sectional studies suggest that 
QOL increases may peak after 1 or 2 years of abstinence 
(Amodeo, Kurtz, and Cutter, 1992). In one, for example, 
participants with 12 to 42 months of abstinence scored 
better on QOL assessments than participants with either 
3 to 12 months or 43 to 108 months of abstinence, and 
scores tailed off as the length of abstinence increased 
(Chaturvedi, Kirthana, and Desai, 1997).
My colleagues and I examined the association 
between abstinence duration and QOL satisfaction in 
two studies with formerly polydrug-dependent persons 
(Table 2) (Laudet, Morgen, and White, 2006; Laudet 
and White, 2008). At recruitment, participants were 
abstinent for 1 month to more than 10 years. In cross-
sectional analyses, overall QOL satisfaction increased 
gradually from about 6 months to more than 3 years of 
abstinence—the latter a duration that is often consid-
ered stable remission. Abstinence duration correlated 
significantly and positively with QOL satisfaction over 
the entire cohort and accounted for 9 percent of the vari-
ance in QOL satisfaction. In prospective analyses, after 
controlling for baseline levels of QOL satisfaction, longer 
abstinence duration at baseline significantly predicted 
higher levels of QOL satisfaction 1 year later. We also 
recently reported that the level of QOL satisfaction at 
the end of outpatient treatment is a significant predic-
tor of commitment to abstinence, which in turn is a 
strong predictor of sustained abstinence (Laudet and 
Stanick, 2010).
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Abstinence Duration at Baseline Mean QOL Standard Deviation N
Less than 6 months 6.75      1.97      99
6 to 18 months 7.51     2.05        92
18 to 36 months 8.13      1.64        71
More than 36 months 8.05     1.79        92
TABLE 2. Quality-of-Life Satisfaction as a Function of  
Abstinence Duration
Participants (N = 354) responded to the question: Overall, how satisfied are you 
with your life? 0 = not at all; 10 = completely (Laudet, Morgen, and White, 2006).
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The longest study of QOL components among indi-
viduals with SUD reassessed alcoholics 2 and 10 years 
after their initial treatment episode (Moos, Finney, and 
Cronkite, 1990). At both followups, participants whose 
drinking remitted (49 percent at 2 years and 57 percent 
at 10 years) had significantly higher levels of physical, 
mental, social, and occupational functioning than did 
the relapsed group. Moreover, compared with a matched 
community-based sample with no dependence history, 
the stably remitted group exhibited few deficits at the 
2-year followup in physical and mental health and func-
tioned equally well at the 10-year followup.
SUD Treatment and QOL
Whereas SUD treatment primarily targets substance 
abuse, it also provides services and referrals aimed at 
alleviating SUD-related problems in areas such as educa-
tion, employment, physical and mental health, family 
functioning, and housing. A growing number of studies 
are examining the impact of treatment per se on QOL, 
including but not limited to any impact on substance 
abuse itself. The investigations completed to date have 
reported treatment-related improvements in most or 
all key QOL areas of functioning, including occupa-
tional status, overall life satisfaction, employment, and 
psychosocial functioning, among both alcohol- and 
drug-dependent samples (Fassino et al., 2004; Foster, 
Marshall, and Peters, 2000; Hubbard et al., 2003; Mor-
gan et al., 2003; Villeneuve et al., 2006).
Recently, Gonzalez and colleagues (2009) measured 
changes in HRQOL as a function of treatment comple-
tion and continued service exposure over a 1-year period 
among methamphetamine abusers. Significant improve-
ments in mental and, to a lesser degree, physical health 
status were observed at followup relative to baseline. To 
explore the role of treatment and aftercare on QOL, the 
researchers modeled the change trajectories in SF-36 
scores in four groups of patients: (1) treatment completers 
who engaged in some type of continuing care for SUD 
problems, (2) treatment completers who did not engage 
in continuing care, (3) noncompleters who engaged in 
continuing care, and (4) noncompleters who did not 
engage in continuing care. After controlling for other 
relevant variables, the researchers found that clients 
who received the greatest number of services (those in 
group 1) during the followup year experienced the most 
improvement in mental health functioning (gains of 
9.6 points, based on normative calculation from the 
U.S. general population ranging from 0 [worst pos-
sible health status], to 100 [best possible health status]), 
whereas those who got the fewest services experienced 
the least improvement (2.2 points). The authors noted 
that “this 7.4 point difference is substantial, showing 
the importance of both successful treatment adherence 
(i.e., treatment completion) and subsequent continued 
care.” There was no association between levels of service 
utilization and physical health status.
QOL as a Promoter of SUD Symptom Reduction
Research on QOL among those with chronic conditions 
has focused thus far on the unidirectional effect of symp-
tom management on QOL—that is, whether symptom 
reduction leads to improved QOL. Another  potentially 
important question is whether the relationship between 
SUD symptoms and QOL may be bidirectional so that 
improvement or deterioration of either can cause a similar 
change in the other. A few researchers have suggested 
that this is the case in chronic diseases other than SUD. 
For example, one group noted that “uncontrolled blood 
pressure alters hypertensive patients’ QOL through 
anxiety and depressive reactions, and poor QOL hampers 
blood pressure control even with a therapeutic regimen” 
(Youssef et al., 2005). By extension, one may ask: Does 
an addicted individual’s QOL satisfaction predict his 
or her subsequent remission?
Behavioral economics and behavior choice theory 
provide useful concepts for framing this question. Drug 
dependence can be understood as a choice, and behavior-
ists ask the question: What factors result in the choice 
of drug over other reinforcers (Bickel and DeGrandpre, 
1996)? A relevant basic principle of choice theory is 
demand law, whereby consumption decreases as “price” 
increases (Allison, 1983). For a former drug abuser, 
the prospect of losing QOL improvements and posi-
tive experiences that accumulate in drug-free periods 
raises the price of reverting to drug use and reinforces 
motivation for continued abstinence. In this context, 
Blomqvist noted that among remitted substance abusers, 
“stability/improvements in several life areas contributed 
to sustaining … [their] resolution [to remain abstinent]” 
(Blomqvist, 2002). Among alcoholic women, higher 
satisfaction with life at treatment intake predicted higher 
subsequent abstinence rates (Rudolf and Priebe, 2002). 
Conversely, low QOL heightened the risk of relapse 
(Foster, Marshall, and Peters, 1998).
Based on demand law, we tested the hypotheses that 
QOL predicts sustained abstinence and that motiva-
tional constructs mediate the association (Laudet et al., 
Does an 
addicted indi-
vidual’s QOL 
satisfaction 
predict his or 
her chances for 
remission?2009). We found that, in a prospective cohort study of 
formerly polysubstance-dependent individuals abstinent 
for 1 month to more than 10 years, controlling for other 
relevant variables, baseline QOL satisfaction predicted 
continuous abstinence (biologically corroborated) 1 
and 2 years later. As we had hypothesized, the associa-
tion was partially mediated by a measure of motivation: 
commitment to abstinence. 
IMPLICATIONS FOR CLINICAL PRACTICE AND 
RESEARCH
We have argued that QOL is highly relevant to SUD and 
recovery and that emerging changes in the SUD service 
field will require the incorporation of QOL indices in 
service development and research. Although the knowl-
edge base is small and suffers from several methodologi-
cal limitations, available evidence suggests that QOL 
is generally poor among active substance abusers and 
treatment seekers, and that reductions in substance abuse, 
including abstinence and participation in professional 
treatment, are associated with QOL improvements. To 
date, only physical and psychological health outcomes 
have been examined systematically, and little is known 
about other important domains of functioning. Here we 
present some suggestions for promoting QOL in SUD 
clinical practice and research questions that will need 
to be addressed to inform SUD service development, 
monitoring, and evaluation.
Implications for Clinical Practice
As discussed above, improvements in the functioning 
domains that constitute QOL are critical components 
of recovery, and thus impairments in these areas must 
be considered in clinical practice. As noted by McLel-
lan and colleagues (2005), “Typically, the immediate 
goal of reducing alcohol and drug use is necessary but 
rarely sufficient for the achievement of the longer-term 
goals of improved personal health and social function 
and reduced threats to public health and safety—i.e., 
recovery.”
  In terms of service development and funding, the ideal 
scenario is the adoption of an integrated, multisystem, 
recovery-oriented model that meets all service needs. 
The emerging ROSC model, an example of such an 
approach, appears to have great potential to address 
not only substance abuse issues but also related service 
needs, and to possibly improve QOL in areas where 
impairments develop, and often endure, after abstinence 
has been achieved. Although the current fiscal austerity 
affecting most States may delay widespread adoption of 
ROSC, some states (e.g., New York) are moving forward, 
while other States and cities, most notably Connecticut 
(White, 2008b) and Philadelphia (White, 2008a), have 
well-established recovery-oriented systems.
The current model of SUD services also harbors 
opportunities to consider and promote QOL. Treatment 
programs routinely assess clients’ functioning in QOL-
related areas such as housing, employment, and family 
functioning using SAMHSA’s Government Performance 
and Results Act (GPRA) Client Outcome Measures. As 
well, many programs offer non-SUD services onsite or 
refer patients to outside agencies for needed services.
Regrettably, the outcome measurement model that 
currently prevails is ill-suited to monitor the impact of 
services on client functioning or identify QOL-related 
service needs. For example, for adult clients, SAMHSA 
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requires that the GPRA be administered at intake, dis-
charge, and 6 months after intake. With this schedule, 
in contrast to standard practice with other chronic con-
ditions, most assessments of patient functioning occur 
after services have ended. McLellan and colleagues (2005) 
have proposed an alternative model, concurrent recovery 
monitoring (CRM), to help clinicians pinpoint areas 
of impairment and newly arising issues on an ongoing 
basis throughout treatment. In CRM, clinicians would 
monitor substance abuse, personal health, social function, 
and behaviors that constitute threats to public health and 
safety at regular intervals during treatment (McLellan 
et al., 2005). A suggested CRM frequency would be 
weekly in intensive outpatient settings and monthly in 
standard  outpatient settings, with each data collection 
requiring no more than 5 minutes per patient.
If CRM were to be adopted, it might be useful to 
include a single OQOL item in CRM assessments, such 
as one taken from the OQOL subscale of the WHO-
QOL: “Overall, how satisfied are you with your life?” 
Although of limited usefulness for research purposes, a 
response to this question is considered an adequate and 
reliable indicator of how a person feels (U.S. Depart-
ment of Health and Human Services, 2000); it has 
been found useful for identifying persons at increased 
risk for adverse health outcomes (Ried et al., 2006); 
and it predicts subsequent sustained abstinence among 
substance abusers (Laudet, Becker, and White, 2009). 
Adding this question to CRM assessments would not 
substantially add to clinicians’ time burden and would 
promote a dialogue with individual clients to identify 
unmet service needs.
  We hold that QOL is critical to the goal of recovery, 
and clinical and recovery-oriented services must include 
improvements in key QOL domains among the goals of 
treatment. The ideal service model for addressing QOL 
is likely to be one that integrates a variety of services and 
provides a continuum of care.
Key Research Questions
The preceding sections indicate that there are many 
more questions than answers with regard to QOL in the 
addictions. Therefore the first implication of this review 
for researchers is the urgent need to broaden the scope 
of outcome evaluations to include standardized QOL 
measures (Cisler et al., 2005). QOL must be embraced 
as a bona fide outcome in SUD research in the same way 
it is in other areas of the mental health and biomedical 
fields. Second, as is often the case in an emerging field, 
the QOL knowledge base suffers from several limitations 
that restrict the generalizability of findings (Cisler et 
al., 2005; Dawson et al., 2009; Donovan et al., 2005; 
Laudet et al., 2009). Future studies need to overcome 
key limitations pertaining to the following methods:
•  Sampling: Most QOL studies have used samples of 
convenience, typically treatment-enrolled individuals, 
precluding generalization to the active abusers who 
are out of treatment and persons in recovery who are 
no longer enrolled in services. Moreover, most QOL 
studies have examined abuse or dependence on alcohol, 
but not other drugs. Given the emerging evidence that 
abuse of other drugs may impair QOL more severely 
than alcohol, more research among current and former 
drug abusers is critically needed;
•  Design: The majority of QOL studies of SUD popula-
tions are cross-sectional, especially those conducted in 
the United States, precluding causal inference. Prospec-
tive studies have used very short followups (3 months 
to 1 year) that are inadequate to capture the full scope 
of change in either substance abuse or QOL or the 
longitudinal association between the two domains;
•  Measurement: Overall, there has been a lack of uni-
formity in the instruments used to measure QOL and 
in the way scores are reported, making cross-study 
comparisons difficult. More importantly, studies have 
almost exclusively used indices of HRQOL, princi-
pally the SF-series instruments, that fail to capture 
functioning in domains—especially social functioning 
and living environment—that are important to SUD-
affected populations and to the recovery experience. 
The WHOQOL instruments offer a very promising 
alternative (Betty Ford Institute Consensus Panel, 
2007), yielding scores in physical, psychological, and 
social functioning; living environment; and an overall 
satisfaction score. The 26-item WHOQOL-BREF 
is used increasingly in biomedical research and prac-
tice worldwide and is slowly being adopted by SUD 
researchers abroad (Bizzarri et al., 2005; Gunther et 
al., 2007) and in the United States—for example, in 
the multisite COMBINE trial funded by the National 
Institute on Alcohol Abuse and Alcoholism (Cisler et 
al., 2005).
The full list of research questions to be addressed 
regarding QOL is beyond the scope of this paper. Key 
areas where investigation is critically needed to guide 
service development and policy, and to augment our 
knowledge of the full impact of addiction and full benefits 
of recovery, include the following:
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•		Identification of all the functional domains that are 
impaired by active SUD and where improvements 
occur as a function of remission. This research is likely 
to benefit from the inclusion of qualitative methods.
•  Thorough assessment of the extent of impairments in 
all key areas of functioning among all segments of the 
SUD-affected population, including out-of-treatment 
active abusers, clients in treatment, and persons in 
successive stages of recovery. This knowledge will help 
pinpoint service and funding needs in primary care, 
specialty care, and recovery-oriented services. It will 
also inform prevention and education efforts.
• Elucidation of longitudinal changes in each QOL 
domain as a function of service and recovery supports 
as well as changes in substance abuse. These studies will 
require long-term followups, similar to that recently 
published by Dawson and colleagues (2009). The 
results will inform service development and funding 
decisions.
•	Specification of correlates and predictors of patterns 
of QOL change beyond fixed characteristics, such 
as demographics and clinical variables, that explain 
but a fraction of the variance in QOL outcomes. For 
instance, research needs to determine the role of posi-
tive and negative recovery capital (Cloud and Gran-
field, 2008), participation in self-help support groups, 
and other forms of recovery support.
•  Exploration of the possibility that QOL prospectively 
influences the odds of abstinence.
•	Consideration of possible subgroup differences, such as 
gender, ethnicity/culture, age, and primary substances 
abused.
In sum, the investigation of QOL in the addiction 
field is in its infancy. Much remains to be done to inform 
service development and policy, guide clinical practice, 
and give substance abusers and all other stakeholder 
groups realistic, empirically based expectations. For-
tunately, researchers studying QOL in SUD can draw 
questions and methodologies from a large body of work 
that has been conducted in the mental health and other 
biomedical fields. Together with the many researchers 
and clinicians who have contributed to developing the 
QOL concept and instruments, I hope that QOL will 
become a bona fide outcome in SUD clinical practice 
and research. Its current relative absence from the field 
represents a notable gap in the knowledge needed to 
promote stable recovery.
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Lucy Zammarelli: I like the way the arti-
cle pulls substance abuse treatment into a 
standardized medical perspective. Quality 
of life is typically a goal in treating many 
diseases other than substance abuse. In 
the drug abuse field, it provides a broader, 
more  encompassing gauge of success than 
just whether the client used a drug or how 
much.
Dave Ross: The issue is extremely important. 
Quality of life doesn’t mean just that some-
body is now sober. It’s much more than that,  
and it takes a multidimensional program 
with some longevity to truly address it.
Zammarelli: The quality-of-life concept 
gives us a way to talk to patients about 
their situation that doesn’t play into the 
shame that surrounds this disease. Instead 
of pathologizing their behavior, we can say, 
“Our goal is to help you succeed in your 
life.”
 
Danny Hall: I practice patient-centered 
care. My perspective is that if you’re truly 
doing patient-centered care, your outcome 
is quality of life. And if you’re doing a good 
job, quality of life will improve.
Instruments and relationships
Zammarelli: I would like to become more 
familiar with the WHOQOL form that’s 
mentioned in the article. We don’t use any-
thing like that in our program.
 Hall: In our program at the VA, we don’t 
objectively measure quality of life. We use 
an assessment called the Brief Addiction 
Measure, which covers quality-of-life issues 
very broadly with questions about mental 
and physical health; cravings; work, school 
and volunteer activities; and religion and 
spirituality. I think that ultimately it will 
be a very useful instrument, but so far we 
don’t have norms on it.
Ross: At Catholic Charities, we give patients 
a form that has check-off boxes for mental 
and addiction issues, general and sexual 
health, chronic medical problems, food, 
clothing, shelter, and so on. Patients fill it 
out at intake and again when they exit the 
program to measure their progress. Most 
importantly, we use it as a clinical tool.
Interestingly, we initially designed the 
form using seven-point Likert scales, but 
that turned out to be too complex for some 
folks at intake. We shortened the form to 
three-point scales, and that has been much 
more successful.
Zammarelli: Our field has much to gain 
from adopting standardized instruments 
like the WHOQOL. We have such eclectic 
working methods; it’ll be good for everyone 
when we can develop a standardized vocabu-
lary. Quantifiable empirical data on quality 
of life will also be very useful.
Hall: Right. Our program just had a visit 
from a tracer for the Joint Committee on the 
Accreditation of Healthcare Organizations 
(JCAHO). She told us that we’re going to 
have to show JCAHO that we are using data 
to guide our decisions about changes to the 
program. They won’t be satisfied with us just 
telling them why we thought something was 
a good idea. We’re going to have to show 
them the data that we generated to help us 
choose between option A and option B. 
Zammarelli: A broadly used instrument like 
the WHOQOL can also relieve stigma. We 
can say to patients, “We’re going to give you 
a screener that’s like one that’s used in heart 
disease and diabetes to help us determine 
our goals in treatment.”
Ross: In my experience, much of the quality-
of-life material that researchers develop tends 
to be top-down. The instruments assess what 
researchers think counts toward quality of 
life. So there will be items on food, clothing, 
shelter, abstinence, and so on. At Catholic 
Charities, we think it’s also important to 
ask clients about quality of life in their own 
frame of reference. For example, have they 
reconnected with their friends, taken up 
a hobby or a sport or something else that 
they used to do?
Zammarelli: Relationships are a key aspect 
of quality of life. Many, many clients have 
had a terrible lack of caring, loving rela-
tionships in their lives. Their empathic 
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